dpp4i and glp 1 GLP-1 receptor agonist versus DPP-4 inhibitor kidney and cardiovascular outcomes in clinical practice in type-2 diabetes Frontiers | Physiology and Pharmacology

Is a ketogenic diet an effective, affordable, and sustainable solution for long-term metabolic health

By combining therapeutic development with delivery innovation, SureNano Science is building a vertically integrated metabolic disease platform rather than focusing solely on a single injectable drug candidate

In a phase 2b randomized clinical trial, bofanglutide demonstrated a strong efficacy in reducing blood sugar in people with type 2 diabetes

These biomarkers should inform provider discussion about titration speed and whether side effect severity warrants dose adjustment or medication formulation change

Data availability Available upon request

After your first month of treatment, you can add the Precision Peptide Genetic Test ($99 add-on) to map your unique peptide pathway and refine medication selection